Randomized Phase II Study to Assess PD 0332991 in Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Untreated Operable Early Breast Cancer
Interventions: DRUG: PD0332991
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris